Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Communications Medicine|May 17, 2025
Regulating the AI-enabled ecosystem for human therapeuticsRominder Singh, Mark Paxton, Jared AuclairFrontiers in Medicine|November 3, 2025
Reimagining drug regulation in the age of AI: a framework for the AI-enabled Ecosystem for TherapeuticsRominder Singh, Karen Zhou, Jared R AuclairJournal of Pharmaceutical Sciences|June 10, 2025
Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, analytical characterization, and regulatory insightSadiqua Shadbar, Sathy Balu Iyer, Jared Auclair, et al.Therapeutic Innovation & Regulatory Science|May 12, 2024
Simultaneous Global Drug Development and Multiregional Clinical Trials (MRCT): 5 Years After Implementation of ICH E17 GuidelinesRominder Singh, William Wang, Aloka Chakravarty, et al.Pharmaceutics|March 28, 2026
Artificial Intelligence and the Transformation of Cell and Gene Therapy DevelopmentJared R Auclair, Jeewon Joung, Maya A Singh, et al.Plos One|June 10, 2022
Performance of the TaqMan COVID-19 Pooling Kit for detection of SARS-CoV-2 in asymptomatic and symptomatic populationsTroy Ganz, Sarah Sanderson, Connor Baush, et al.Frontiers in Drug Safety and Regulation|March 25, 2026
Federating AI-related regulations for human therapeutics: an AI-enabled, continuously updating regulatory intelligence systemRominder Singh, Mukesh Pareek, Michael Prokle, et al.Journal of Pharmaceutical and Biomedical Analysis|July 19, 2005
In vitro metabolism of a thrombin inhibitor and quantitation of metabolically generated cyanideC Charles Lin, Bradley K Wong, Christopher S Burgey, et al.Journal of Medical Imaging and Radiation Oncology|October 10, 2012
Adherence to Canadian C-Spine Rule in a regional hospital: a retrospective study of 406 casesMark Paxton, Clare F Heal, Herwig DrobetzJCO Clinical Cancer Informatics|September 30, 2024
Informatics and Artificial Intelligence-Guided Assessment of the Regulatory and Translational Research Landscape of First-in-Class Oncology Drugs in the United States, 2018-2022Jay G Ronquillo, Brett South, Prakash Naik, et al.Pageof 2